Faure, Jean-Emmanuel
Dyląg, Tomasz
Norstedt, Irene
Matthiessen, Line
Article History
First Online: 19 July 2018
Compliance with Ethical Standards
:
: No funding sources were used to assist with the preparation of this manuscript. Costs for ensuring Open Access to this article have been covered by the European Commission.
: Irene Norstedt is a member of the Innovative Medicines Initiative Governing Board, representing the European Commission, and Line Matthiessen has been member until 30 June 2018. Tomasz Dyląg and Jean-Emmanuel Faure are observers at the Innovative Medicines Initiative Governing Board meetings, representing the European Commission.